Giuseppe Coppolino1, Davide Bolignano2, Pietro Gareri3, Carmen Ruberto3, Michele Andreucci4, Giovanni Ruotolo5, Maurizio Rocca3, Alberto Castagna3. 1. Nephrology and Dialysis Unit, "Pugliese-Ciaccio" General Hospital, Via Michele Torcia, 4, 88100, Catanzaro, Italy. gcoppolino@hotmail.it. 2. Institute of Clinical Physiology, CNR - Italian National Council of Research, Reggio Calabria, Italy. 3. Center for Cognitive Disorders and Dementia, Azienda Sanitaria Provinciale di Catanzaro, Catanzaro, Italy. 4. Renal Unit, Department of Health Sciences, "Magna Graecia" University, Catanzaro, Italy. 5. Geriatric Unit, "Pugliese-Ciaccio" General Hospital, Catanzaro, Italy.
Abstract
BACKGROUND AND AIMS: Cognitive and renal impairment are pervasive among elderly frails, a high-risk, geriatric sub-population with peculiar clinical characteristics. In a series of frail individuals with non-advanced chronic kidney disease (CKD), we aimed at assessing the entity of functional, general health and cognitive impairment and the possible relationship between these types of dysfunction and the severity of renal impairment. METHODS: 2229 geriatric subjects were screened for frailty and CKD. Severity of CKD was assessed by eGFR (CKD-EPI formula). Frailty was established by the Fried Index. Functional, general health and cognitive status were assessed by validated score measures. RESULTS: Final analysis included 271 frail CKD subjects (162 women, 109 men). Mean eGFR was 64.25 ± 25.04 mL/min/1.73 m2. Prevalence of mild-to-moderate CKD (stage 3-4) was 44%. Twenty-six percent of patients had severe cognitive impairment, while mild and moderate impairment was found in 7 and 67% of individuals, respectively. All subjects had poor functional and general health status. Cognitive capacities significantly decreased across CKD stages (p for trend < 0.0001). In fully adjusted multivariate analyses, cognitive status remained an independent predictor of eGFR (β = 0.465; p < 0.0001). CONCLUSIONS: Mild-to-moderate CKD is highly pervasive among frail elderly individuals and the severity of renal dysfunction is independently correlated with that of cognitive impairment. Future studies are advocated to clarify whether the combination of kidney and mental dysfunction may portend a higher risk of worsen outcomes in this high-risk population.
BACKGROUND AND AIMS: Cognitive and renal impairment are pervasive among elderly frails, a high-risk, geriatric sub-population with peculiar clinical characteristics. In a series of frail individuals with non-advanced chronic kidney disease (CKD), we aimed at assessing the entity of functional, general health and cognitive impairment and the possible relationship between these types of dysfunction and the severity of renal impairment. METHODS: 2229 geriatric subjects were screened for frailty and CKD. Severity of CKD was assessed by eGFR (CKD-EPI formula). Frailty was established by the Fried Index. Functional, general health and cognitive status were assessed by validated score measures. RESULTS: Final analysis included 271 frail CKD subjects (162 women, 109 men). Mean eGFR was 64.25 ± 25.04 mL/min/1.73 m2. Prevalence of mild-to-moderate CKD (stage 3-4) was 44%. Twenty-six percent of patients had severe cognitive impairment, while mild and moderate impairment was found in 7 and 67% of individuals, respectively. All subjects had poor functional and general health status. Cognitive capacities significantly decreased across CKD stages (p for trend < 0.0001). In fully adjusted multivariate analyses, cognitive status remained an independent predictor of eGFR (β = 0.465; p < 0.0001). CONCLUSIONS: Mild-to-moderate CKD is highly pervasive among frail elderly individuals and the severity of renal dysfunction is independently correlated with that of cognitive impairment. Future studies are advocated to clarify whether the combination of kidney and mental dysfunction may portend a higher risk of worsen outcomes in this high-risk population.
Authors: Kristine Yaffe; Lynn Ackerson; Manjula Kurella Tamura; Patti Le Blanc; John W Kusek; Ashwini R Sehgal; Debbie Cohen; Cheryl Anderson; Lawrence Appel; Karen Desalvo; Akinlolu Ojo; Stephen Seliger; Nancy Robinson; Gail Makos; Alan S Go Journal: J Am Geriatr Soc Date: 2010-01-26 Impact factor: 5.562
Authors: Sofie Vermeiren; Roberta Vella-Azzopardi; David Beckwée; Ann-Katrin Habbig; Aldo Scafoglieri; Bart Jansen; Ivan Bautmans Journal: J Am Med Dir Assoc Date: 2016-12-01 Impact factor: 4.669
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Christian Leporini; Anna Pisano; Emilio Russo; Graziella D Arrigo; Giovambattista de Sarro; Giuseppe Coppolino; Davide Bolignano Journal: Pharmacol Res Date: 2016-03-17 Impact factor: 7.658
Authors: Debbie Rankin; Michaela Black; Bronac Flanagan; Catherine F Hughes; Adrian Moore; Leane Hoey; Jonathan Wallace; Chris Gill; Paul Carlin; Anne M Molloy; Conal Cunningham; Helene McNulty Journal: JMIR Med Inform Date: 2020-09-16